Hereditary Cancer Syndromes. From: Archives of Pathology & Laboratory Medicine | Date: January 1, 2001| Author: Frank, Thomas S. | COPYRIGHT 2001 College of American Pathologists. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

Objective.--To summarize the biological basis, clinical implications, identification, and medical management of syndromes associated with increased risk of common adult cancers.

Data Sources.--Recent studies and data available from molecular and clinical analysis of genes responsible for autosomal-dominant inheritance of cancer risk.

Data Synthesis.--Several hereditary cancer syndromes have been identified for which there are increasingly effective diagnostic and managemen...

Related newspaper, magazine, and journal articles from HighBeam Research

	Identifying hereditary cancer syndromes.(GENETICS IN YOUR PRACTICE) Internal Medicine News ; In the Dec. 1, 2007, issue of INTERNAL MEDICINE NEWS, Dr. Michael F. Murray reviewed the importance of the family health history as a risk assessment tool for internists. The renewed ...
	An examination of cancer risk beliefs among adults from Toronto's Somali, Chinese, Russian and Spanish-speaking communities Canadian Journal of Public Health ; ABSTRACT Background: Canada's growing ethnocultural diversity challenges health professionals to develop culturally sensitive cancer prevention strategies. Little is known about the ethnocultural specificity of cancer risk beliefs. This qualitative pilot study examined cancer risk beliefs, focusing
	A Research Agenda for Biomarkers as Indicators of Cancer Risk Reduction Following Dietary Manipulation1,2 The Journal of Nutrition ; Background The U.S. government has convened several public meetings and workshops to explore the role of biomarkers as tools for cancer detection and for assessing cancer risk. In 1999 NIH and FDA held a workshop entitled Bioiuarkers and Surrogate Endpoints: Clinical Research and Applications (1).
	Firms to Stop Urging Pesticide's Use on Some Crops;Unusual Voluntary Ban Follows Report Showing Unacceptably High Cancer Risk The Washington Post ; Three chemical companies announced yesterday that they immediately will stop recommending use of a popular pesticide on certain crops because of its high cancer risk. The unusual voluntary ban on dozens of uses of ethylene bisdithiocarbanate (EBDCs) follows release this summer of a National
	First of numerous cancer risk notices go out to neighbors of local businesses. (Los Angeles, California worksites) Los Angeles Business Journal ; Two L.A.-based worksites have been told to notify their neighbors that their toxic emissions pose a cancer risk and hold public meetings to address the risk, the South Coast Air Quality Management District announced last week. These two notifications are the first of dozens to be made to nearby

See all results.